These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29550258)

  • 1. Live bacterial vaccine vector and delivery strategies of heterologous antigen: A review.
    Ding C; Ma J; Dong Q; Liu Q
    Immunol Lett; 2018 May; 197():70-77. PubMed ID: 29550258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can a 'flawless' live vector vaccine strain be engineered?
    Galen JE; Levine MM
    Trends Microbiol; 2001 Aug; 9(8):372-6. PubMed ID: 11514219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live bacterial vaccine vectors: an overview.
    da Silva AJ; Zangirolami TC; Novo-Mansur MT; Giordano Rde C; Martins EA
    Braz J Microbiol; 2014; 45(4):1117-29. PubMed ID: 25763014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of live attenuated bacteria as a delivery system for heterologous antigens.
    Garmory HS; Leary SE; Griffin KF; Williamson ED; Brown KA; Titball RW
    J Drug Target; 2003; 11(8-10):471-9. PubMed ID: 15203915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asd-based balanced-lethal system in attenuated Edwardsiella tarda to express a heterologous antigen for a multivalent bacterial vaccine.
    Yan Y; Mu W; Zhang L; Guan L; Liu Q; Zhang Y
    Fish Shellfish Immunol; 2013 May; 34(5):1188-94. PubMed ID: 23454428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens.
    Stevenson A; Roberts M
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):121-8. PubMed ID: 12832115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the development of live, attenuated bacterial vectors.
    Roland KL; Tinge SA; Killeen KP; Kochi SK
    Curr Opin Mol Ther; 2005 Feb; 7(1):62-72. PubMed ID: 15732531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-penetrating peptides mediated protein cross-membrane delivery and its use in bacterial vector vaccine.
    Ma J; Xu J; Guan L; Hu T; Liu Q; Xiao J; Zhang Y
    Fish Shellfish Immunol; 2014 Jul; 39(1):8-16. PubMed ID: 24746937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA.
    Galen JE; Zhao L; Chinchilla M; Wang JY; Pasetti MF; Green J; Levine MM
    Infect Immun; 2004 Dec; 72(12):7096-106. PubMed ID: 15557633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quorum sensing-based in vivo expression system and its application in multivalent bacterial vaccine.
    Chu T; Ni C; Zhang L; Wang Q; Xiao J; Zhang Y; Liu Q
    Microb Cell Fact; 2015 Mar; 14():37. PubMed ID: 25888727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioengineering a bacterial pathogen to assemble its own particulate vaccine capable of inducing cellular immunity.
    Lee JW; Parlane NA; Wedlock DN; Rehm BH
    Sci Rep; 2017 Feb; 7():41607. PubMed ID: 28150705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery.
    Lin IY; Van TT; Smooker PM
    Vaccines (Basel); 2015 Nov; 3(4):940-72. PubMed ID: 26569321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins.
    Husseiny MI; Hensel M
    Vaccine; 2009 Jun; 27(28):3780-7. PubMed ID: 19464562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A stable plasmid system for heterologous antigen expression in attenuated Vibrio anguillarum.
    Xiao Y; Liu Q; Chen H; Zhang Y
    Vaccine; 2011 Sep; 29(40):6986-93. PubMed ID: 21791231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant live Salmonella spp. for human vaccination against heterologous pathogens.
    Bumann D; Hueck C; Aebischer T; Meyer TF
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):357-64. PubMed ID: 10727892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems.
    Pontes DS; de Azevedo MS; Chatel JM; Langella P; Azevedo V; Miyoshi A
    Protein Expr Purif; 2011 Oct; 79(2):165-75. PubMed ID: 21704169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel in vivo inducible expression system in Edwardsiella tarda for potential application in bacterial polyvalence vaccine.
    Mu W; Guan L; Yan Y; Liu Q; Zhang Y
    Fish Shellfish Immunol; 2011 Dec; 31(6):1097-105. PubMed ID: 21964456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Salmonella vectors in vaccine development.
    Curtiss R; Kelly SM; Tinge SA; Tacket CO; Levine MM; Srinivasan J; Koopman M
    Dev Biol Stand; 1994; 82():23-33. PubMed ID: 7958478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic intervention alternatives in cancer, using attenuated live bacterial vectors: Salmonella enterica as a carrier of heterologous molecules].
    Hernández-Luna MA; Luria-Pérez R; Huerta-Yépez S
    Rev Invest Clin; 2013; 65(1):65-73. PubMed ID: 23745445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.